Bio-Rad Laboratories Inc (BIO)
325.58
+1.89
(+0.58%)
USD |
NYSE |
Nov 21, 16:00
327.10
+1.52
(+0.47%)
Pre-Market: 09:27
Bio-Rad Laboratories Gross Profit Margin (Quarterly): 54.78% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 54.78% |
| June 30, 2024 | 55.62% |
| March 31, 2024 | 53.37% |
| December 31, 2023 | 53.78% |
| September 30, 2023 | 53.10% |
| June 30, 2023 | 53.22% |
| March 31, 2023 | 53.55% |
| December 31, 2022 | 54.38% |
| September 30, 2022 | 54.72% |
| June 30, 2022 | 57.16% |
| March 31, 2022 | 57.51% |
| December 31, 2021 | 54.37% |
| September 30, 2021 | 58.56% |
| June 30, 2021 | 56.09% |
| March 31, 2021 | 55.12% |
| December 31, 2020 | 58.27% |
| September 30, 2020 | 56.75% |
| June 30, 2020 | 54.57% |
| March 31, 2020 | 55.52% |
| December 31, 2019 | 52.92% |
| September 30, 2019 | 54.76% |
| June 30, 2019 | 53.75% |
| March 31, 2019 | 56.28% |
| December 31, 2018 | 53.91% |
| September 30, 2018 | 52.60% |
| Date | Value |
|---|---|
| June 30, 2018 | 52.38% |
| March 31, 2018 | 54.79% |
| December 31, 2017 | 55.57% |
| September 30, 2017 | 55.98% |
| June 30, 2017 | 54.17% |
| March 31, 2017 | 54.01% |
| December 31, 2016 | 55.07% |
| September 30, 2016 | 54.93% |
| June 30, 2016 | 54.23% |
| March 31, 2016 | 56.03% |
| December 31, 2015 | 54.07% |
| September 30, 2015 | 56.06% |
| June 30, 2015 | 55.25% |
| March 31, 2015 | 57.13% |
| December 31, 2014 | 53.06% |
| September 30, 2014 | 54.38% |
| June 30, 2014 | 55.37% |
| March 31, 2014 | 54.05% |
| December 31, 2013 | 53.56% |
| September 30, 2013 | 56.27% |
| June 30, 2013 | 57.13% |
| March 31, 2013 | 54.32% |
| December 31, 2012 | 54.81% |
| September 30, 2012 | 54.90% |
| June 30, 2012 | 56.40% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
52.92%
Minimum
Dec 2019
58.56%
Maximum
Sep 2021
55.17%
Average
54.75%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Agilent Technologies Inc | 54.18% |
| Bruker Corp | 48.45% |
| Azenta Inc | 40.82% |
| Harvard Bioscience Inc | 58.10% |
| Bionano Genomics Inc | -139.1% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -9.62% |
| Return on Assets | -6.82% |
| Return on Invested Capital | -8.38% |
| Operating Margin (Quarterly) | 9.92% |
| Return on Net Operating Assets | -27.53% |